Arianne Shadi Kourosh, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermatology | 10 | 2023 | 871 | 1.910 |
Why?
|
Cosmetic Techniques | 2 | 2023 | 133 | 1.460 |
Why?
|
Deoxycholic Acid | 3 | 2023 | 47 | 1.180 |
Why?
|
Adiposis Dolorosa | 1 | 2023 | 12 | 0.910 |
Why?
|
Patient Advocacy | 2 | 2014 | 353 | 0.790 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 2 | 2011 | 125 | 0.750 |
Why?
|
Lipoma | 1 | 2023 | 335 | 0.750 |
Why?
|
Dermatologic Agents | 4 | 2018 | 274 | 0.660 |
Why?
|
Drug Eruptions | 1 | 2021 | 295 | 0.640 |
Why?
|
Body Dysmorphic Disorders | 1 | 2020 | 229 | 0.580 |
Why?
|
Body Image | 1 | 2020 | 608 | 0.530 |
Why?
|
Leprosy, Lepromatous | 1 | 2013 | 23 | 0.480 |
Why?
|
Sunburn | 1 | 2015 | 155 | 0.480 |
Why?
|
Erythema Nodosum | 1 | 2013 | 30 | 0.470 |
Why?
|
Mycobacterium leprae | 1 | 2013 | 97 | 0.460 |
Why?
|
Dermatitis, Atopic | 1 | 2019 | 644 | 0.440 |
Why?
|
Needs Assessment | 7 | 2023 | 1145 | 0.430 |
Why?
|
Mucous Membrane | 2 | 2011 | 667 | 0.380 |
Why?
|
Referral and Consultation | 2 | 2014 | 3514 | 0.380 |
Why?
|
Sunbathing | 1 | 2010 | 60 | 0.360 |
Why?
|
Awareness | 1 | 2014 | 639 | 0.350 |
Why?
|
Patient Compliance | 1 | 2019 | 2679 | 0.340 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2013 | 703 | 0.310 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5128 | 0.260 |
Why?
|
Pain | 1 | 2020 | 4923 | 0.260 |
Why?
|
Behavior, Addictive | 1 | 2010 | 460 | 0.250 |
Why?
|
Pandemics | 2 | 2022 | 8274 | 0.250 |
Why?
|
South Dakota | 1 | 2023 | 31 | 0.230 |
Why?
|
Health Behavior | 1 | 2015 | 2624 | 0.230 |
Why?
|
Rosacea | 1 | 2023 | 49 | 0.220 |
Why?
|
Autoantibodies | 1 | 2011 | 2020 | 0.220 |
Why?
|
Health Promotion | 1 | 2015 | 2187 | 0.220 |
Why?
|
Hyperlipidemias | 1 | 2008 | 785 | 0.220 |
Why?
|
Software | 2 | 2014 | 4423 | 0.220 |
Why?
|
Telemedicine | 1 | 2019 | 2844 | 0.210 |
Why?
|
Neurotoxins | 1 | 2023 | 237 | 0.210 |
Why?
|
Injections, Subcutaneous | 1 | 2023 | 664 | 0.200 |
Why?
|
Academies and Institutes | 1 | 2023 | 316 | 0.200 |
Why?
|
Drug Repositioning | 1 | 2023 | 232 | 0.190 |
Why?
|
Medically Underserved Area | 1 | 2023 | 254 | 0.190 |
Why?
|
Physicians | 2 | 2019 | 4539 | 0.180 |
Why?
|
Psoriasis | 1 | 2008 | 888 | 0.180 |
Why?
|
Subcutaneous Fat | 1 | 2023 | 392 | 0.180 |
Why?
|
Autoimmune Diseases | 1 | 2011 | 2116 | 0.170 |
Why?
|
Advisory Committees | 1 | 2023 | 770 | 0.170 |
Why?
|
Drug Costs | 2 | 2017 | 1115 | 0.170 |
Why?
|
Internship and Residency | 4 | 2022 | 5761 | 0.170 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4143 | 0.160 |
Why?
|
Rare Diseases | 1 | 2023 | 553 | 0.160 |
Why?
|
Skin Neoplasms | 2 | 2015 | 5632 | 0.160 |
Why?
|
Skin Diseases | 2 | 2018 | 1065 | 0.150 |
Why?
|
Humans | 25 | 2023 | 739398 | 0.150 |
Why?
|
Off-Label Use | 1 | 2018 | 168 | 0.150 |
Why?
|
Nurse Practitioners | 1 | 2019 | 270 | 0.140 |
Why?
|
Appointments and Schedules | 1 | 2019 | 415 | 0.140 |
Why?
|
Self Concept | 1 | 2022 | 1024 | 0.130 |
Why?
|
Communicable Disease Control | 1 | 2022 | 853 | 0.130 |
Why?
|
Pharmaceutical Services | 1 | 2016 | 140 | 0.130 |
Why?
|
Telecommunications | 1 | 2014 | 80 | 0.120 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2016 | 336 | 0.120 |
Why?
|
Aftercare | 1 | 2019 | 858 | 0.120 |
Why?
|
United States Food and Drug Administration | 2 | 2018 | 1584 | 0.110 |
Why?
|
Texas | 1 | 2014 | 394 | 0.110 |
Why?
|
Organizations | 1 | 2013 | 167 | 0.110 |
Why?
|
Societies, Medical | 4 | 2022 | 3739 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1409 | 0.100 |
Why?
|
Drug Utilization | 1 | 2017 | 1181 | 0.100 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3844 | 0.090 |
Why?
|
Models, Theoretical | 1 | 2021 | 3609 | 0.080 |
Why?
|
Politics | 1 | 2015 | 782 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2527 | 0.080 |
Why?
|
United States | 6 | 2023 | 69573 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2010 | 1059 | 0.070 |
Why?
|
Quality of Life | 2 | 2023 | 12640 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2008 | 11699 | 0.060 |
Why?
|
Flushing | 1 | 2023 | 49 | 0.060 |
Why?
|
Adult | 5 | 2022 | 213394 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15070 | 0.050 |
Why?
|
Erythema | 1 | 2023 | 254 | 0.050 |
Why?
|
Skin | 1 | 2013 | 4324 | 0.040 |
Why?
|
Female | 7 | 2018 | 378853 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9684 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3730 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12948 | 0.040 |
Why?
|
Male | 6 | 2018 | 349022 | 0.040 |
Why?
|
Patient Care | 1 | 2022 | 638 | 0.040 |
Why?
|
Young Adult | 1 | 2022 | 56255 | 0.030 |
Why?
|
Lobbying | 1 | 2015 | 32 | 0.030 |
Why?
|
American Medical Association | 1 | 2015 | 65 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 9812 | 0.030 |
Why?
|
Child | 2 | 2019 | 77033 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 2010 | 4239 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10362 | 0.030 |
Why?
|
Drug Approval | 1 | 2018 | 742 | 0.030 |
Why?
|
Drugs, Generic | 1 | 2016 | 423 | 0.020 |
Why?
|
Mental Disorders | 1 | 2010 | 6570 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2448 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3575 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10534 | 0.020 |
Why?
|
Medicare | 2 | 2016 | 6497 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3341 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12643 | 0.020 |
Why?
|
Motivation | 1 | 2015 | 1965 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1206 | 0.020 |
Why?
|
Health Personnel | 1 | 2017 | 3203 | 0.010 |
Why?
|
Health Expenditures | 1 | 2016 | 2348 | 0.010 |
Why?
|
Medicaid | 1 | 2016 | 2711 | 0.010 |
Why?
|
Health Policy | 1 | 2015 | 2655 | 0.010 |
Why?
|
Risk Factors | 1 | 2008 | 71974 | 0.010 |
Why?
|
Middle Aged | 1 | 2014 | 212863 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 24714 | 0.010 |
Why?
|